Corrigendum to “Co-delivery of all-trans-retinoic acid and doxorubicin for cancer therapy with synergistic inhibition of cancer stem cells” [Biomaterials 37 (2015) 405–414]
- Resource Type
- Erratum
- Source
- In
Biomaterials December 2020 263 - Subject
- Language
- ISSN
- 0142-9612